2021-01-04,b'Can you post your Bull and Bear case for $BFT $BTWN $FUSE please? \n\n$MFAC $SMMC $INAQ $SPCE $SRAC $NPA $OPEN $PRCH $GHIV $APXT $CFII $WPF $ROCH $FSRV $STIC $IPOC $GIX $LGVW $OAC $BRPA $JWS $PSTH $VGAC $QELL $IPOE $IPOF $CCAC $ATAC $FUSE $AJAX $FTOC $SOAC $SNPR $IPOD $ENPC $AACQ'
2021-01-04,b'$INAQ (Metromile)\n$BFT (Paysafe)\n$APXT (AvePoint)\n$IPOC (CloverHealth)\n$GHIV (United Wholesale Mortgage)\n$STPK (STEM) \n$JWS (Cano Health) \n$NBAC (Nuvve)\n$AMCI (Advent Technologies) \n$ALAC (SolarMax Tech) \n$CFII (View) \n$ROCH (PureCycle Technologies)'
2021-01-04,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-04,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-04,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'One of my favorite dark horses $ROCH go check out purecycle if you haven\xe2\x80\x99t https://t.co/S9cmQ18IfA'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-03,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-02,b'#SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companies to SPAC with the highest degree of execution risk.\n\n$CLA $GIK $NBAC $IPV $CGRO $AMCI $SRAC $FIII $NOVS $ROCH $CIIC $NPA https://t.co/DMQKpQWgLd'
2021-01-02,b'Picking up trash never looked this good.\xf0\x9f\x92\xaf $LOAK $ROCH \n\xe2\x99\xbb\xef\xb8\x8f\xe2\x99\xbb\xef\xb8\x8f\xe2\x99\xbb\xef\xb8\x8f\xe2\x99\xbb\xef\xb8\x8f = \xf0\x9f\x92\xb0\xf0\x9f\x92\xb0\xf0\x9f\x92\xb0\xf0\x9f\x92\xb0 https://t.co/T07Mc0CAfF'
2021-01-01,b'@alexcutler247 $LGVW - Butterfly Network\n$CIIC - Arrival\n$DKNG - Draft Kings\n$ROCH - Pure Cycle\n$DM - Desktop Metal\n$STPK - Stem'
2021-01-01,b'@alexcutler247 $ROCH will be bit#g'
2020-12-31,b'I\xe2\x80\x99m ready for Q1 \xe2\x9c\x88\xef\xb8\x8f\xe2\x9c\x88\xef\xb8\x8f\xe2\x9c\x88\xef\xb8\x8f\n$STPK $BFT $THBR $DMYD $NOVS $LGVW $AMCI $GIK $NBAC $INAQ $BFI $LAC $ROCH $NGA $SMMC $NPA\nThese ain\xe2\x80\x99t rumors.\xf0\x9f\xa5\xa9\xf0\x9f\xa5\xa9\xf0\x9f\xa5\xa9\xf0\x9f\xa5\xa9 https://t.co/TILfWGrFqF'
2020-12-31,b'$dnmr safekeeping in the IRA $loak $roch \xe2\x99\xbb\xef\xb8\x8f https://t.co/1mfAI07kNh'
2020-12-31,b'$ROCH has an average technical rating and it also does not offer a high quality setup at the moment. https://t.co/t5SLJBy66W https://t.co/FnUJIo0vT6'
2020-12-30,b'RT @watch_view: My portfolio\n$QS Energy for the future\n$NOVS next generation of farmers\n$CIIC city mobility\n$BNTX the epidemic cure\n$ROCH C\xe2\x80\xa6'
2020-12-30,b'My portfolio\n$QS Energy for the future\n$NOVS next generation of farmers\n$CIIC city mobility\n$BNTX the epidemic cure\n$ROCH Cleaning the planet\n$ABCL the AI of big pharma\n$BFI tasty free time\n$APXT Following Bill\n$THCB European Energy\n$AHT being optimistic'
2020-12-30,b'$ROCH should pick up like $DNMR old $LOAK; ESG play'
2020-12-30,b'@bear_fuker Have you looked at $roch? Also roth ii is super interesting with all the shares the insiders are buying I wish I had some liquidity'
2020-12-30,"b'@SaidGouss @alexcutler247 If you\xe2\x80\x99re going to pay premium for a spac, it should be for a damn good reason. Current \xe2\x80\x9cgood reasons\xe2\x80\x9d in that price range: $ROCH $INAQ $NBAC $NGA\nDont pay a premium for a RUMOR. Thats chasing/fomo. \xf0\x9f\x92\xaf Grab your rumors sub $12 and be patient. There\xe2\x80\x99s  a ton right now.'"
2020-12-30,b'Roth CH Acquisition I Co Shares Climb 1.0% Past Previous 52-Week High - Market Mover https://t.co/i8lJlVqQ6N $ROCH #stockmarket #kwhenfinance'
2020-12-29,b'$LOAK added this for a bounce overnight at $23.62 it\xe2\x80\x99s similar to $ROCH in terms of plastics recyclables play. Great leadership team'
2020-12-28,"b'@BreakoutPoint @StoneriverAdvi1 On its way, I think... check out $ROCH. They\xe2\x80\x99re destined to buy some fantastic, totally legit company. Their long track record speaks for itself... https://t.co/cKFg3oBXvB'"
2020-12-28,b'@SpacBobby $ROCH Purecycle merger!!'
2020-12-28,"b'@Aurividerci very mature and sound response. Definitely have to change up strategies when the market flips on you. These are my other plays currently:\n\nRMG, THCB, DGNR, RTP, BTWN, BFT, SVAC, SPNV, ATAC, BTAQ, $ROCH and LEAP'"
2020-12-28,b'Get medicated. \xf0\x9f\xa5\xa6\xf0\x9f\x92\xa8  It\xe2\x80\x99s just #stocks.\xf0\x9f\xa5\xa9\xf0\x9f\xa5\xa9\xf0\x9f\xa5\xa9 $LOAK $ROCH https://t.co/1qzXd4twix'
2020-12-28,b'RT @PatternProfits: Daily Velocity Scan for 12/9. 38 names (+769). $QS stays red hot. Money also flowing into SPAC names again with $ROCH $\xe2\x80\xa6'
2020-12-28,"b""RT @PatternProfits: Daily Velocity Scan for 12/4. 60 names (+695). $SI is a beast! Semi's hot - $COHU $AMBA $UCTT $AEIS $TSEM $MTSI represe\xe2\x80\xa6"""
2020-12-28,b'New 52 Week High today: $EDUT $APXT $MASS $AJAX $IMPX $TRS $MCRI $PSCH $ROCH $RMT $EW $BMI $PHB $ATRC $LANDO $CHI $SRAC $BNED $ATAC $ROCCU ... https://t.co/4Iw0QeR3p8'
2020-12-28,b'How is everyone sleeping on $roch? Once this gets volume headed to $30'
2020-12-28,b'RT @spacsto: SPACs on fire\xf0\x9f\x94\xa5\n$PIC +26%\n$BFT  +6%\n$IPOC +9%\n$FIII +5%\n$ROCH +7%\n$GIK +13%\n$RMG +9%\n$SRAC +11%\nTo name just a few.\nAny other b\xe2\x80\xa6'
2020-12-28,"b'SPACS on my radar this week are: \n\n$RMG, DGNR, RTP, $BTWN, BFT, SVAC, SPNV, ATAC, BTAQ, $ROCH and LEAP\n\nThese have tremendous potential and will do well in 2021 and beyond. Get in these now due to the management teams alon... https://t.co/L9iL2GWqID'"
2020-12-27,b'$ROCH PureCycle Technologies merger.. Testing break out here.. Looking to hold that break out.. https://t.co/benc9PIsIh'
2021-01-08,"b""@agnostoxxx @Belk95 @agnostoxxx: thanks for your response! may be a dumb question, but what's the company name for $ROCH? All I'm finding is Roche Holding AG (pharmaceutical company)"""
2021-01-08,b'@CapitalMorty @Belk95 Personally long Renewi and $ROCH warrants. My in-price is quite different from current levels so do your own due diligence pls! Was also long Derichebourg but sold recentlly'
2021-01-07,b'Scan results - Hammer Candlestick today: $ADC $THCA $BABA $BIP $VRSN $MNR $NNN $CBD $REXR $TCOM $ROCH $CERE ... https://t.co/7dhTJaDJG6'
2021-01-07,b'Jan. 7 @SPACListing tracks for you.\n\n\xf0\x9f\x94\xa5Top 5 Gainers\n$IPOE +44.22%\n$AGCB +34.40%\n$CCNC + 29.82%\n$STPK +15.84%\n$LGHL +14.85%\n\n\xf0\x9f\x94\xbbTop 5 Losers \n$RMG -15.47%\n$TOTA -12.46%\n$ORSN -9.53%\n$DMYT 6.26%\n$ROCH -4.98%\n\nFollow us \n@spaclisting\n\n#spaclisting #spac #ipo #mergers #nyse #nasdaq'
2021-01-07,b'Name someone that loves $NOVS like me. \xf0\x9f\xa4\x91\n\nBeing a hippie never looked this good\xf0\x9f\x92\xaf\n\n$ROCH $LOAK https://t.co/a0NBxGcUwM'
2021-01-07,"b""$ETHE coming back to buy zone. I like the 12's if they will get there. \n\n$ROCH also giving buying ops today"""
2021-01-07,b'20 DMA Support today: $SCA $JMUB $ROCH $BRG ... https://t.co/deOpbNqdR6'
2021-01-07,b'RT @eezeemonee: I\xe2\x80\x99m different. $NOVS $LOAK $ROCH https://t.co/myVMSOd18A'
2021-01-07,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-07,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-07,b'RT @DJohnson_CPA: #SPAC Target screen\n\n&lt; $20M revenue in 2020 (excluding biopharm/drug dev. targets)\n\nThese are the earliest stage companie\xe2\x80\xa6'
2021-01-06,b'RT @watch_view: My portfolio\n$QS Energy for the future\n$NOVS next generation of farmers\n$CIIC city mobility\n$BNTX the epidemic cure\n$ROCH C\xe2\x80\xa6'
2021-01-06,b'RT @watch_view: My portfolio\n$QS Energy for the future\n$NOVS next generation of farmers\n$CIIC city mobility\n$BNTX the epidemic cure\n$ROCH C\xe2\x80\xa6'
2021-01-06,b'RT @watch_view: My portfolio\n$QS Energy for the future\n$NOVS next generation of farmers\n$CIIC city mobility\n$BNTX the epidemic cure\n$ROCH C\xe2\x80\xa6'
